Publications

Garabrant D, Pastula S. Asbestos and EMP fiber potency analysis. Abstract and oral presentation, Monticello Conference, Charlottesville, VA, October 2017.

Rager JE, Ring CL, Fry RC, Suh M, Proctor DM, Haws L, Harris MA, Thompson CM. 2017. High-throughput screening data interpretation in the context of in vivo transcriptomic responses to oral Cr(VI) exposure. Toxicol Sci 158(1):199–212; doi: 10.1093/toxsci/kfx085. PMID: 28472532.

Young LE, Sacks NC, Cyr PL, Sharma A, Dahdal DH. Rates of hospitalization and repeat procedures in patients receiving sodium picosulfate/magnesium citrate bowel preparation prior to colonoscopy. Society of Gastroenterology Nurses and Associates, New Orleans LA, 2017.

Frausto SF, Sacks NC, Cyr PL, Sharma A, Dahdal DH, Brogadir S. Hospitalization for hyponatremia and dehydration in patients receiving sodium picosulfate/magnesium citrate bowel preparation prior to colonoscopy. World Congress of Gastroenterology-ACG 2017, Orlando, FL, October 2017.

Young LE, Sacks NC, Cyr PL, Sharma A, Dahdal DH, Brogadir S. Rates of incomplete and repeat screens in patients receiving sodium picosulfate/magnesium citrate bowel preparation prior to colonoscopy versus other low volume bowel preparations. World Congress of Gastroenterology ACG, 2017.

Wu E, Jensen IS, Cyr PL, Kisner H. Economic model shows that guideline recommended testing of patients with early symptoms of myeloma results in improved patient outcomes and decreased hospital costs. American Society of Hematology, Atlanta GA, 2017.

Jensen IS, Wu E, Cyr PL, Gauden D. Cost-consequence of use of Fluciclovine (F 18) for the diagnosis and staging of recurring prostate cancer. ISPOR 16th Annual European Congress, Glasgow, Scotland, 2017.

Berger K, Rossi G, Orlando V, Fabry P, Jensen IS, Gallacher ME, et al. Mobilizing stem cells with plerixafor in MM patients: Impact on a health care provider’s budget in Germany and Italy. 43rd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 2017.

Kirman CR, Suh M, Proctor DM, Hays SM. 2017. Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populations. Toxicol Appl Pharmacol 325(15 June):9-17; doi: 10.1016/j.taap.2017.03.023. PMID: 28389273.

Jensen IS, Wu E, Sacks N, Cyr P, Chung K. 2017. Budget impact analysis of CPX-351 in the treatment of patients with treatment-related acute myeloid leukemia (tAML) or AML with myelodysplasia-related changes (MRC) from a US payer perspective. Blood 130(Sup 1):5615; 10.1182/blood.V130.Suppl_1.5615.5615.